Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rani Therapeutics Holdings

1.21
-0.0900-6.92%
Post-market: 1.210.00000.00%18:41 EDT
Volume:184.85K
Turnover:225.84K
Market Cap:40.31M
PE:-1.15
High:1.27
Open:1.25
Low:1.17
Close:1.30
Loading ...

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Immutep Ltd (OtherPRRUF)

TIPRANKS
·
18 Nov 2024

Rani Therapeutics Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
16 Nov 2024

Maxim Group Remains a Buy on Rani Therapeutics Holdings (RANI)

TIPRANKS
·
16 Nov 2024

Rani Therapeutics' Weight-Loss Drugs Can Serve Specific Needs -- Market Talk

Dow Jones
·
16 Nov 2024

Rani Therapeutics Hldgs Q3 EPS $(0.24) Beats $(0.27) Estimate

Benzinga
·
14 Nov 2024

Rani Therapeutics Holdings Inc: Qtrly Loss per Share $0.24

THOMSON REUTERS
·
14 Nov 2024

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

THOMSON REUTERS
·
14 Nov 2024

Rani Therapeutics Q3 Net Income USD -12.722 Million

THOMSON REUTERS
·
14 Nov 2024

Press Release: Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

Dow Jones
·
14 Nov 2024

Rani Therapeutics Holdings Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
14 Nov 2024

Rani Therapeutics Holdings options imply 12.6% move in share price post-earnings

TIPRANKS
·
09 Nov 2024

Rani Therapeutics Holdings Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
07 Nov 2024

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
24 Oct 2024

RANI: New Triagonist Data in Weight Loss

Zacks Small Cap Research
·
22 Oct 2024

Analysts Are Bullish on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Rani Therapeutics Holdings (RANI)

TIPRANKS
·
18 Oct 2024

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of Glp-1 Incretin Triagonist

THOMSON REUTERS
·
17 Oct 2024

Rani Therapeutics Holdings Inc - New Data Supports Ranipill Platform for Oral Obesity Treatments

THOMSON REUTERS
·
17 Oct 2024

Rani Therapeutics Holdings Inc - Phase 1 Study for Rt-114 Expected to Initiate in 2025

THOMSON REUTERS
·
17 Oct 2024

Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced

MT Newswires Live
·
16 Oct 2024

Rani Therapeutics Holdings Inc - Combined Purchase Price of $3.00 per Share

THOMSON REUTERS
·
15 Oct 2024